细胞免疫治疗概念继续活跃
证券时报e公司讯，细胞免疫治疗概念继续活跃，冠昊生物、开能健康高开超10%，中源协和、南华生物竞价涨停，赤天化、泰林生物等高开。
“特别声明：以上作品内容(包括在内的视频、图片或音频)为凤凰网旗下自媒体平台“大风号”用户上传并发布，本平台仅提供信息存储空间服务。
Notice: The content above (including the videos, pictures and audios if any) is uploaded and posted by the user of Dafeng Hao, which is a social media platform and merely provides information storage space services.”
